First Financial Bankshares’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.59M | Buy |
28,578
+807
| +3% | +$101K | 0.08% | 83 |
|
|
2025
Q1 | $3.07M | Buy |
27,771
+829
| +3% | +$91.7K | 0.07% | 81 |
|
|
2024
Q4 | $3.68M | Buy |
26,942
+9,208
| +52% | +$1.26M | 0.08% | 81 |
|
|
2024
Q3 | $2.04M | Buy |
17,734
+1,058
| +6% | +$122K | 0.04% | 93 |
|
|
2024
Q2 | $2.3M | Buy |
16,676
+483
| +3% | +$66.5K | 0.05% | 87 |
|
|
2024
Q1 | $2.23M | Buy |
16,193
+391
| +2% | +$53.9K | 0.05% | 91 |
|
|
2023
Q4 | $2.08M | Buy |
+15,802
| New | +$2.08M | 0.05% | 93 |
|